Advertisement
Screener

ONCOSEC MEDICAL INCORPORATED Operating Cash Flow

ONCOSEC MEDICAL INCORPORATED Operating Cash Flow

ONCOSEC MEDICAL INCORPORATED reported Operating Cash Flow of -$12.74 million for the 6-month period ending 2023-01-31, per its 10-Q filed 2023-03-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-03-14

  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2023-01-31 was -$6.61M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2022-10-31 was -$6.13M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2022-07-31 was -$6.92M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for the quarter ending 2022-04-30 was -$5.34M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for fiscal 2022 was -$32.14M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for fiscal 2021 was -$41.79M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for fiscal 2020 was -$33.15M.
  • ONCOSEC MEDICAL INCORPORATED net cash provided by (used in) operating activities for fiscal 2019 was -$29.00M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2023-01-31-$6.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14
-$12.74M
10-Q · filed 2023-03-14
-$19.65M
derived: sum of 3 quarters · filed 2023-03-14
-$24.99M
derived: sum of 4 quarters · filed 2023-03-14
2022-10-31-$6.13M
10-Q · filed 2022-12-15
-$13.04M
derived: sum of 2 quarters · filed 2022-12-15
-$18.38M
derived: sum of 3 quarters · filed 2022-12-15
-$28.40M
derived: sum of 4 quarters · filed 2023-03-14
2022-07-31-$6.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31
-$12.26M
derived: sum of 2 quarters · filed 2022-10-31
-$22.27M
derived: sum of 3 quarters · filed 2023-03-14
-$32.14M
10-K · filed 2022-10-31
2022-04-30-$5.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14
-$15.35M
derived: sum of 2 quarters · filed 2023-03-14
-$25.22M
10-Q · filed 2022-06-14
-$33.63M
derived: sum of 4 quarters · filed 2023-03-14
2022-01-31-$10.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14
-$19.88M
10-Q · filed 2023-03-14
-$28.29M
derived: sum of 3 quarters · filed 2023-03-14
-$41.09M
derived: sum of 4 quarters · filed 2023-03-14
2021-10-31-$9.87M
10-Q · filed 2022-12-15
-$18.27M
derived: sum of 2 quarters · filed 2022-12-15
-$31.07M
derived: sum of 3 quarters · filed 2022-12-15
-$41.92M
derived: sum of 4 quarters · filed 2022-12-15
2021-07-31-$8.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31
-$21.20M
derived: sum of 2 quarters · filed 2022-10-31
-$32.06M
derived: sum of 3 quarters · filed 2022-10-31
-$41.79M
10-K · filed 2022-10-31
2021-04-30-$12.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14
-$23.65M
derived: sum of 2 quarters · filed 2022-06-14
-$33.39M
10-Q · filed 2022-06-14
-$42.75M
derived: sum of 4 quarters · filed 2022-06-14
2021-01-31-$10.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-03-15
-$20.59M
10-Q · filed 2022-03-15
-$29.95M
derived: sum of 3 quarters · filed 2022-03-15
-$38.16M
derived: sum of 4 quarters · filed 2022-03-15
2020-10-31-$9.74M
10-Q · filed 2021-12-15
-$19.10M
derived: sum of 2 quarters · filed 2021-12-15
-$27.31M
derived: sum of 3 quarters · filed 2021-12-15
-$34.75M
derived: sum of 4 quarters · filed 2021-12-15
2020-07-31-$9.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-29
-$17.57M
derived: sum of 2 quarters · filed 2021-10-29
-$25.01M
derived: sum of 3 quarters · filed 2021-10-29
-$33.15M
10-K · filed 2021-10-29
2020-04-30-$8.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-11
-$15.65M
derived: sum of 2 quarters · filed 2021-06-11
-$23.78M
10-Q · filed 2021-06-11
-$31.88M
derived: sum of 4 quarters · filed 2021-06-11
2020-01-31-$7.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-15
-$15.57M
10-Q · filed 2021-03-15
-$23.66M
derived: sum of 3 quarters · filed 2021-03-15
-$31.35M
derived: sum of 4 quarters · filed 2021-03-15
2019-10-31-$8.13M
10-Q · filed 2020-12-11
-$16.22M
derived: sum of 2 quarters · filed 2020-12-11
-$23.91M
derived: sum of 3 quarters · filed 2020-12-11
-$30.36M
derived: sum of 4 quarters · filed 2020-12-11
2019-07-31-$8.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-28
-$15.78M
derived: sum of 2 quarters · filed 2020-10-28
-$22.23M
derived: sum of 3 quarters · filed 2020-10-28
-$29.00M
10-K · filed 2020-10-28
2019-04-30-$7.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-15
-$14.13M
derived: sum of 2 quarters · filed 2020-06-15
-$20.91M
10-Q · filed 2020-06-15
-$27.13M
derived: sum of 4 quarters · filed 2020-06-15
2019-01-31-$6.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-16
-$13.23M
10-Q · filed 2020-03-16
-$19.45M
derived: sum of 3 quarters · filed 2020-03-16
-$25.24M
derived: sum of 4 quarters · filed 2020-03-16
2018-10-31-$6.78M
10-Q · filed 2019-12-13
-$13.00M
derived: sum of 2 quarters · filed 2019-12-13
-$18.79M
derived: sum of 3 quarters · filed 2019-12-13
-$24.92M
derived: sum of 4 quarters · filed 2019-12-13
2018-07-31-$6.22M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-27
-$12.01M
derived: sum of 2 quarters · filed 2019-11-27
-$18.14M
derived: sum of 3 quarters · filed 2019-11-27
-$23.22M
10-K/A · filed 2019-11-27
2018-04-30-$5.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-14
-$11.92M
derived: sum of 2 quarters · filed 2019-06-14
-$17.00M
10-Q · filed 2019-06-14
-$21.63M
derived: sum of 4 quarters · filed 2019-06-14
2018-01-31-$6.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-08
-$11.21M
10-Q · filed 2019-03-08
-$15.84M
derived: sum of 3 quarters · filed 2019-03-08
2017-10-31-$5.08M
10-Q · filed 2018-12-14
-$9.71M
derived: sum of 2 quarters · filed 2018-12-14
2017-07-31-$4.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-19
-$17.34M
10-K · filed 2018-10-19
2017-04-30-$12.71M
10-Q · filed 2018-06-13